Travere Therapeutics, Inc.
TVTX
50 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Apr 11 11:03 PM | Christopher Cline | Proposed Sale | 48 | $13.14 | $631 | — | View → |
| Feb 12, 2025 | Feb 13 12:47 AM | Peter Heerma | Proposed Sale | 2,568 | $23.53 | $60.4K | — | View → |
| Feb 12, 2025 | Feb 13 12:46 AM | Jula Inrig | Proposed Sale | 2,568 | $23.53 | $60.4K | — | View → |
| Feb 12, 2025 | Feb 12 4:03 PM | ROTE WILLIAM E. | Proposed Sale | 5,200 | $23.53 | $122.4K | — | View → |
| Feb 12, 2025 | Feb 12 2:52 PM | REED ELIZABETH E | Proposed Sale | 8,000 | $23.53 | $188.2K | — | View → |
| Feb 11, 2025 | Feb 11 9:08 PM | SANDRA CALVIN | Proposed Sale | 54,244 | $25.00 | $1.4M | — | View → |
| Feb 11, 2025 | Feb 11 9:04 PM | PETER HEERMA | Proposed Sale | 3,074 | $25.00 | $76.8K | — | View → |
| Feb 11, 2025 | Feb 11 4:56 PM | Dube Eric M | Proposed Sale | 11,375 | $24.04 | $273.5K | — | View → |
| Feb 6, 2025 | Feb 6 9:21 PM | ROY D BAYNES | Proposed Sale | 10,000 | $22.00 | $220.0K | — | View → |
| Feb 4, 2025 | Feb 4 9:11 PM | JULA INRIG | Proposed Sale | 1,066 | $20.11 | $21.4K | — | View → |
| Feb 3, 2025 | Feb 4 1:47 AM | Peter Heerma | Proposed Sale | 5,166 | $20.12 | $103.9K | — | View → |
| Feb 3, 2025 | Feb 4 1:46 AM | Christopher Cline | Proposed Sale | 5,192 | $20.12 | $104.5K | — | View → |
| Feb 3, 2025 | Feb 4 1:41 AM | Sandra Calvin | Proposed Sale | 3,348 | $20.12 | $67.4K | — | View → |
| Feb 3, 2025 | Feb 4 1:40 AM | Jula Inrig | Proposed Sale | 4,207 | $20.12 | $84.6K | — | View → |
| Feb 3, 2025 | Feb 3 5:26 PM | REED ELIZABETH E | Proposed Sale | 8,951 | $19.78 | $177.1K | — | View → |
| Feb 3, 2025 | Feb 3 4:22 PM | Dube Eric M | Proposed Sale | 50,691 | $19.78 | $1.0M | — | View → |
| Feb 3, 2025 | Feb 3 4:11 PM | ROTE WILLIAM E. | Proposed Sale | 8,951 | $19.78 | $177.1K | — | View → |
| Jan 23, 2025 | Jan 23 9:14 PM | ROY D BAYNES | Proposed Sale | 16,000 | $20.00 | $320.0K | — | View → |
| Jan 22, 2025 | Jan 22 3:34 PM | Dube Eric M | Proposed Sale | 10,736 | $19.46 | $208.9K | — | View → |
| Jan 22, 2025 | Jan 22 3:18 PM | REED ELIZABETH E | Proposed Sale | 2,437 | $19.46 | $47.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 30,000(D) | View → |
← Previous
Page 3 of 3